APA (7th ed.) Citation

KELLOFF, G. J., SIGMAN, C. C., JOHNSON, K. M., BOONE, C. W., GREENWALD, P., CROWELL, J. A., . . . DOODY, L. A. (2000). Perspectives on Surrogate End Points in the Development of Drugs that Reduce the Risk of Cancer. Cancer epidemiology, biomarkers & prevention, 9(2), 127-137.

Chicago Style (17th ed.) Citation

KELLOFF, G. J., C. C. SIGMAN, K. M. JOHNSON, C. W. BOONE, P. GREENWALD, J. A. CROWELL, E. T. HAWK, and L. A. DOODY. "Perspectives on Surrogate End Points in the Development of Drugs That Reduce the Risk of Cancer." Cancer Epidemiology, Biomarkers & Prevention 9, no. 2 (2000): 127-137.

MLA (9th ed.) Citation

KELLOFF, G. J., et al. "Perspectives on Surrogate End Points in the Development of Drugs That Reduce the Risk of Cancer." Cancer Epidemiology, Biomarkers & Prevention, vol. 9, no. 2, 2000, pp. 127-137.